Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

1.

ACTH and azathioprine: antiproteinuric and lipid-lowering effect in the course of idiopathic membranous glomerulonephritis.

Gigante A, Rosato E, Liberatori M, Gasperini ML, Giannakakis K, Barbano B, Cianci R, Salsano F, Amoroso A.

J Biol Regul Homeost Agents. 2012 Jan-Mar;26(1):135-8.

PMID:
22475105
[PubMed - indexed for MEDLINE]
2.

A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy.

Ponticelli C, Altieri P, Scolari F, Passerini P, Roccatello D, Cesana B, Melis P, Valzorio B, Sasdelli M, Pasquali S, Pozzi C, Piccoli G, Lupo A, Segagni S, Antonucci F, Dugo M, Minari M, Scalia A, Pedrini L, Pisano G, Grassi C, Farina M, Bellazzi R.

J Am Soc Nephrol. 1998 Mar;9(3):444-50.

PMID:
9513907
[PubMed - indexed for MEDLINE]
Free Article
3.

Case series of idiopathic membranous nephropathy with long-term beneficial effects of ACTH peptide 1-24.

Rauen T, Michaelis A, Floege J, Mertens PR.

Clin Nephrol. 2009 Jun;71(6):637-42.

PMID:
19473632
[PubMed - indexed for MEDLINE]
4.

Cyclosporine versus azathioprine therapy in high-risk idiopathic membranous nephropathy patients: A 3-year prospective study.

Naumovic R, Jovanovic D, Pavlovic S, Stosovic M, Marinkovic J, Basta-Jovanovic G.

Biomed Pharmacother. 2011 Mar;65(2):105-10. doi: 10.1016/j.biopha.2010.10.009. Epub 2010 Nov 5.

PMID:
21109389
[PubMed - indexed for MEDLINE]
5.

Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.

Goumenos DS, Ahuja M, Davlouros P, El Nahas AM, Brown CB.

Clin Nephrol. 2006 May;65(5):317-23.

PMID:
16724651
[PubMed - indexed for MEDLINE]
6.

[Membranous glomerulonephritis].

Scheidat S, Stahl RA.

Internist (Berl). 2003 Sep;44(9):1120-30. Review. German.

PMID:
14566465
[PubMed - indexed for MEDLINE]
7.

An overview of immunosuppressive therapy in idiopathic membranous nephropathy.

Maas R, Hofstra JM, Wetzels JF.

Minerva Med. 2012 Aug;103(4):253-66. Review.

PMID:
22805618
[PubMed - indexed for MEDLINE]
8.

Are cytotoxic agents beneficial in idiopathic membranous nephropathy? A meta-analysis of the controlled trials.

Imperiale TF, Goldfarb S, Berns JS.

J Am Soc Nephrol. 1995 Feb;5(8):1553-8.

PMID:
7756587
[PubMed - indexed for MEDLINE]
Free Article
9.

Cyclophosphamide or chlorambucil therapy is indicated in idiopathic membranous nephropathy with strong risk factors for progression.

Hebert LA, Rovin BH, Agarwal AK, Spetie DN.

Am J Kidney Dis. 2005 Apr;45(4):788-9; author replyy 789-90. No abstract available.

PMID:
15806488
[PubMed - indexed for MEDLINE]
10.

[Immunosuppressive treatment of idiopathic membranous glomerulonephritis with nephrotic syndrome].

Muslimović A, Rasić S, Rebić D, Uncanin S.

Med Arh. 2009;63(4):187-90. Bosnian.

PMID:
20088170
[PubMed - indexed for MEDLINE]
11.

[Application of guidelines in clinical practice: a multicenter analysis of the treatment of membranous glomerulonephritis in Piedmont, Italy].

Rollino C, Coppo R, Giacchino F, Savoldi S, Manganaro M, Amore A, Colla L, Ferro M, Demicheli G, Berutti S, Burdese M, Paternoster G, Cravero R, Benozzi L, Vagelli G, Messuerotti A, Licata C, Bainotti S, Patti RR, Quaglia M, Costantini L, Stratta P, Segoloni G; Gruppo Piemontese di Nefrologia Clinica.

G Ital Nefrol. 2010 Nov-Dec;27(6):639-48. Italian.

PMID:
21132646
[PubMed - indexed for MEDLINE]
12.

20 years after methylprednisolone/chlorambucil treatment in idiopathic membranous nephropathy stage II-III with nephrotic syndrome.

Polenakovic M, Grcevska L, Dzikova S.

Prilozi. 2006 Dec;27(2):5-12.

PMID:
17211287
[PubMed - indexed for MEDLINE]
13.

Oral cyclophosphamide versus chlorambucil in the treatment of patients with membranous nephropathy and renal insufficiency.

Branten AJ, Reichert LJ, Koene RA, Wetzels JF.

QJM. 1998 May;91(5):359-66.

PMID:
9709470
[PubMed - indexed for MEDLINE]
Free Article
14.

Idiopathic membranous nephropathy and nephrotic syndrome: outcome in the era of evidence-based therapy.

McQuarrie EP, Stirling CM, Geddes CC.

Nephrol Dial Transplant. 2012 Jan;27(1):235-42. doi: 10.1093/ndt/gfr220. Epub 2011 May 10.

PMID:
21558430
[PubMed - indexed for MEDLINE]
Free Article
15.

The therapy of idiopathic membranous glomerulonephritis.

Glassock RJ.

Semin Nephrol. 1991 Mar;11(2):138-47. Review.

PMID:
2034923
[PubMed - indexed for MEDLINE]
16.

A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy.

Ponticelli C, Passerini P, Salvadori M, Manno C, Viola BF, Pasquali S, Mandolfo S, Messa P.

Am J Kidney Dis. 2006 Feb;47(2):233-40.

PMID:
16431252
[PubMed - indexed for MEDLINE]
17.

Cyclophosphamide provides no additional benefit to steroid therapy in the treatment of idiopathic membranous nephropathy.

Alexopoulos E, Sakellariou G, Memmos D, Karamitsos K, Leontsini M, Papadimitriou M.

Am J Kidney Dis. 1993 May;21(5):497-503.

PMID:
8488817
[PubMed - indexed for MEDLINE]
18.

Conventional treatment of idiopathic nephrotic syndrome and membranous nephropathy in adults.

Ponticelli C, Passerini P.

Clin Nephrol. 1991;35 Suppl 1:S16-21. Review.

PMID:
1860261
[PubMed - indexed for MEDLINE]
19.

Long-term immunosuppressive therapy of idiopathic membranoproliferative glomerulonephritis.

Orlowski T, Rancewicz Z, Lao M, Juskowa J, Klepacka J, Gradowska L, Morzycka-Michalik M, Glyda J.

Klin Wochenschr. 1988 Oct 17;66(20):1019-23.

PMID:
3148785
[PubMed - indexed for MEDLINE]
20.

Idiopathic membranous nephropathy: outline and rationale of a treatment strategy.

du Buf-Vereijken PW, Branten AJ, Wetzels JF.

Am J Kidney Dis. 2005 Dec;46(6):1012-29. Review.

PMID:
16310567
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk